Risk Assessment for Different Formulations in a Highly Potent Drug Facility: Oral Solid Dose & Liquid Dosage Formulations

Time: 3:45 pm
day: Day One


• Understanding how to risk access cross contamination for OSD or liquid dosage formulations, including parenteral

• Considering how different states of compound influence reactor charging and how to navigate this whilst considering the different risks associated with these processes and adapting safety procedures accordingly

• Designing facilities and robust workflow and safety processes to reduce risk of operator exposure in the event of a leak or airborne dust from milling